Innotox is a patented medication approved by the Korean Drug&Food Administration in 2013. This revolutionary botulinum toxin (of Type A) is injectable. Such a drug is a liquid with 4U/0.1ml concentration, entirely ready for use. The consistency of the medicine has been improved, so it does not need to be mixed with saline. It helps to eliminate the risk of incorrect dosage and the ingress of dangerous bacteria. The toxin can save its quality for almost 36 months if stored correctly.
It is important to note that the delivery of the drug is entirely safe, so Innotox will not be at risk of botulism. Among the distinguishing features, the molecular weight of this medicine is 900 kDa (by results of SE-HPLC size exclusion). This toxin might be compared with Neuronox and Botox; all of them have the Hall strain of C.botulinum.
The particular uniqueness of this toxin lies in its composition, where there are no components of animal origin. It means that all the risks associated with animal-based protein are reduced. Typically, human serum albumin was taken for such a drug. But this is not the case with Innotox. Here, experts have found an excellent replacement – methionine and polysorbate. Such elements are safe and have good stabilizing properties.
The safety and efficacy of this toxin have been tested. The research involved 168 subjects, and the tests were conducted at a randomized, double-blinded multicenter level. In the study were the persons with frown lines. They were given 20U of Innotox or Botox. After the injection, the specialists conducted an examination; they didn’t know which injection each patient received. The analysis showed no allergic reactions, and all involved persons had no side effects.
Innotox is “bio-better” than many of its analogs because all elements of animal-based origin have been replaced with natural plant-based ones. It is also important that the effect of this drug is much longer. If we consider high-quality facelift surgery, then its cost can be huge. But the price of Innotox is much more affordable, only $400 (for a standard dose). It is more convenient, easier, and cheaper for patients to use this drug when compared with other Botulinum toxin analogs. Injections do not need to be done frequently, only once every 4-6 months.
Botox global corporation Allergan has already signed a contract with Innotox for international marketing (except in Japan and Korea). The corporation highly appreciates the herbal components of this toxin and is ready to give 365 million dollars to acquire a license for the innovative neurotoxin Medytox.